RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today published its annual letter to stockholders on the Company's website at www.regenerx.com.
RegeneRx Publishes Annual Letter to Shareholders
-
Sponsored -
Agency/Corporate ProgramDavid S. Brown Adds Michael Gosnell to Retail Leasing Team
David S. Brown Enterprises has bolstered its Retail Leasing team with the recent hiring of Michael Gosnell
Gentry Locke Promotes Scott Stephenson to Partner
The Virginia law firm Gentry Locke is pleased to announce the promotion of Scott A. Stephenson to
Pessin Katz Law Attorney Adam E. Konstas Selected To Member
Pessin Katz Law is pleased to announce that Attorney Adam E. Konstas has been elected to Member
Gary Orton Joins Skanska USA Building’s Greater Washington, DC Region as VP and Account Manager
Skanska, a leading global construction and development firm, announces that Gary Orton has joined the company as
TRUSTED BY
THESE PARTNERS:
